BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33780214)

  • 1. Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma: A Systematic Review and Meta-analysis.
    Mohan BP; Chandan S; Khan SR; Kassab LL; Ponnada S; Artifon ELA; Otoch JP; McDonough S; Adler DG
    J Clin Gastroenterol; 2022 Feb; 56(2):e153-e160. PubMed ID: 33780214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial.
    Yang J; Wang J; Zhou H; Zhou Y; Wang Y; Jin H; Lou Q; Zhang X
    Endoscopy; 2018 Aug; 50(8):751-760. PubMed ID: 29342492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
    Tarar ZI; Farooq U; Gandhi M; Ghous G; Saleem S; Kamal F; Imam Z; Jamil L
    Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):646-653. PubMed ID: 37129575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials.
    Song S; Jin H; Cheng Q; Gong S; Lv K; Lei T; Tian H; Li X; Lei C; Yang W; Yang K; Guo T
    Surg Endosc; 2022 Aug; 36(8):5559-5570. PubMed ID: 35296949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
    Jarosova J; Zarivnijova L; Cibulkova I; Mares J; Macinga P; Hujova A; Falt P; Urban O; Hajer J; Spicak J; Hucl T
    Gut; 2023 Nov; 72(12):2286-2293. PubMed ID: 37652677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis.
    Moole H; Tathireddy H; Dharmapuri S; Moole V; Boddireddy R; Yedama P; Dharmapuri S; Uppu A; Bondalapati N; Duvvuri A
    World J Gastroenterol; 2017 Feb; 23(7):1278-1288. PubMed ID: 28275308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.
    Cui W; Wang Y; Fan W; Lu M; Zhang Y; Yao W; Li J
    Int J Hyperthermia; 2017 Nov; 33(7):853-861. PubMed ID: 28540797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis.
    Sofi AA; Khan MA; Das A; Sachdev M; Khuder S; Nawras A; Lee W
    Gastrointest Endosc; 2018 Apr; 87(4):944-951.e1. PubMed ID: 29108980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial.
    Gao DJ; Yang JF; Ma SR; Wu J; Wang TT; Jin HB; Xia MX; Zhang YC; Shen HZ; Ye X; Zhang XF; Hu B
    Gastrointest Endosc; 2021 Jul; 94(1):91-100.e2. PubMed ID: 33359435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving biliary stent patency for malignant obstructive jaundice using endobiliary radiofrequency ablation: experience in 150 patients.
    Kong YL; Zhang HY; Liu CL; He XJ; Zhao G; Wang C; Kong LH; Zhao J
    Surg Endosc; 2022 Mar; 36(3):1789-1798. PubMed ID: 33788032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma.
    Li Z; Jiang X; Xiao H; Chen S; Zhu W; Lu H; Cao L; Xue P; Li H; Zhang D
    Surg Endosc; 2021 Oct; 35(10):5655-5664. PubMed ID: 33104917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.
    Gerhardt T; Rings D; Höblinger A; Heller J; Sauerbruch T; Schepke M
    Z Gastroenterol; 2010 Jan; 48(1):28-32. PubMed ID: 20072993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL.
    Kang H; Chung MJ; Cho IR; Jo JH; Lee HS; Park JY; Park SW; Song SY; Bang S
    Surg Endosc; 2021 Jan; 35(1):63-73. PubMed ID: 32488654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis.
    Song S; Gong S; Lei T; Tian H; Lu T; Lei C; Jin H; Yang W; Yang K; Guo T
    Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):555-567. PubMed ID: 35639826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term disease control by endobiliary radiofrequency ablation in localized extrahepatic cholangiocarcinoma: a first case report.
    Inoue T; Ibusuki M; Kitano R; Ito K
    Clin J Gastroenterol; 2023 Dec; 16(6):908-912. PubMed ID: 37615832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Intraductal Radiofrequency Ablation for Extrahepatic Distal Cholangiocarcinoma: A Method for Prolonging Stent Patency and Achieving Better Functional Status and Quality of Life.
    Wu TT; Li WM; Li HC; Ao GK; Zheng F; Lin H
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):260-269. PubMed ID: 27743089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma.
    Inoue T; Naitoh I; Kitano R; Ibusuki M; Kobayashi Y; Sumida Y; Nakade Y; Ito K; Yoneda M
    Curr Oncol; 2022 Mar; 29(4):2240-2251. PubMed ID: 35448156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Radiofrequency Ablation Along With Stenting Versus Stenting Alone for Biliary Tree Drainage in Patients With Malignant Biliary Strictures: A Systemic Review and Meta-analysis.
    Hayat U; Ashfaq MZ; Haseeb M; Farhan ML; Kamal MU; Talib KA; Khan HMA; Siddiqui AA
    J Clin Gastroenterol; 2024 Mar; 58(3):297-306. PubMed ID: 37039475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.